

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Plat...
Q2 2026
Jul 30, 2026
Q1 2026
Apr 28, 2026
FY 2025
Feb 26, 2026
Q4 2025
Feb 26, 2026
Q3 2025
Oct 28, 2025